139 related articles for article (PubMed ID: 35703962)
21. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
22. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
23. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
[TBL] [Abstract][Full Text] [Related]
24. The impact of sentinel node dissection on disease-free and overall tumour-specific survival in melanoma patients: a single centre group-matched analysis of 1192 patients.
Geimer T; Sattler EC; Flaig MJ; Ruzicka T; Berking C; Schmid-Wendtner MH; Kunte C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):629-635. PubMed ID: 27556957
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
26. Is incisional biopsy of melanoma harmful?
Martin RC; Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Edwards MJ; McMasters KM
Am J Surg; 2005 Dec; 190(6):913-7. PubMed ID: 16307945
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of partial biopsies in the management of cutaneous melanoma.
Doolan BJ; Robinson AJ; Wolfe R; Kelly JW; McLean C; McCormack C; Henderson MA; Pan Y
Australas J Dermatol; 2019 Aug; 60(3):209-213. PubMed ID: 30773625
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma.
Kelemen PR; Essner R; Foshag LJ; Morton DL
J Am Coll Surg; 1999 Sep; 189(3):247-52. PubMed ID: 10472924
[TBL] [Abstract][Full Text] [Related]
29. Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma.
Falk Delgado A; Zommorodi S; Falk Delgado A
Curr Oncol Rep; 2019 Apr; 21(6):54. PubMed ID: 31028497
[TBL] [Abstract][Full Text] [Related]
30. Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
Jakub JW; Lowe M; Howard JH; Farma JM; Sarnaik A; Tuttle T; Neuman HB; Ariyan CE; Uppal A; Trocha S; Beasley GM; Wasif N; Bilimoria KY; Thomay AA; Allred JB; Chen L; Terando AM; Wayne JD; Thompson JF; Cochran AJ; Sim MS; Elashoff DE; Delman KA; Faries MB
Ann Surg Oncol; 2022 Sep; 29(9):5910-5920. PubMed ID: 35499783
[TBL] [Abstract][Full Text] [Related]
31. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.
Kachare SD; Brinkley J; Wong JH; Vohra NA; Zervos EE; Fitzgerald TL
Ann Surg Oncol; 2014 Oct; 21(11):3377-85. PubMed ID: 25063010
[TBL] [Abstract][Full Text] [Related]
32. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
33. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
Sladden M; Zagarella S; Popescu C; Bigby M
Br J Dermatol; 2015 Mar; 172(3):566-71. PubMed ID: 25776246
[TBL] [Abstract][Full Text] [Related]
34. Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report'.
Faries MB; Cochran AJ; Elashoff RM; Thompson JF
Br J Dermatol; 2015 Mar; 172(3):571-3. PubMed ID: 25776247
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
36. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
37. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
Demer AM; Hanson JL; Maher IA; Liszewski W
JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853
[TBL] [Abstract][Full Text] [Related]
38. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma.
Thomas JM
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):442-6. PubMed ID: 19246272
[TBL] [Abstract][Full Text] [Related]
39. Delayed harvesting of sentinel lymph nodes after previous wide local excision of extremity melanoma.
Leong SP; Thelmo MC; Kim RP; Gokhale R; Rhee JY; Achtem TA; Morita E; Allen RE; Kashani-Sabet M; Sagebiel RW
Ann Surg Oncol; 2003 Mar; 10(2):196-200. PubMed ID: 12620917
[TBL] [Abstract][Full Text] [Related]
40. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
